Dr Joseph D Scott, DO | |
2 Springbrook Dr, Biddeford, ME 04005-9443 | |
(207) 282-1500 | |
(207) 282-2581 |
Full Name | Dr Joseph D Scott |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 12 Years |
Location | 2 Springbrook Dr, Biddeford, Maine |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346503380 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | DO2632 (Maine) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mainehealth | 7517860588 | 2067 |
News Archive
Top Institute Pharma, which carries out pioneering research projects with the support of the Dutch Ministry of Health in order to develop better and safer medicines, is starting a unique research project designed to reduce maternal and child mortality.
The director of the Planned Parenthood abortion center in Bryan/College Station, Texas has resigned her job. Abby Johnson had worked at the clinic for eight years, but departed from the facility following a profound change of heart about abortion. The Planned Parenthood clinic was the location of the first-ever 40 Days for Life campaign in the fall of 2004, and the prayer and fasting initiative has been held outside the doors of Johnson's former workplace five additional times since 40 Days for Life began its rapid spread to 282 cities across all 50 states and several other countries.
The U.S. Food and Drug Administration today announced that Peng Bandith, owner of the Lao Trading Company of Nashville has signed a consent decree that permanently prohibits Lao Trading Co. from distributing food held under insanitary conditions in interstate commerce.
CEVEC Pharmaceuticals, the German developer of a novel human expression system derived from amniocytes, announced today the signing of an exclusive license option agreement with Pevion Biotech, the Swiss vaccine company. The agreement enables Pevion Biotech to exclusively use CEVEC's transient CAP-T™ cell expression technology to manufacture and commercialize a protein antigen for vaccination against a widespread human infectious disease.
Isis Pharmaceuticals, Inc. today provided an update on its ongoing open-label Phase 2 clinical study of ISIS-SMN Rx in infants with Type I spinal muscular atrophy (SMA).
› Verified 9 days ago
Entity Name | Mainehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Top Institute Pharma, which carries out pioneering research projects with the support of the Dutch Ministry of Health in order to develop better and safer medicines, is starting a unique research project designed to reduce maternal and child mortality.
The director of the Planned Parenthood abortion center in Bryan/College Station, Texas has resigned her job. Abby Johnson had worked at the clinic for eight years, but departed from the facility following a profound change of heart about abortion. The Planned Parenthood clinic was the location of the first-ever 40 Days for Life campaign in the fall of 2004, and the prayer and fasting initiative has been held outside the doors of Johnson's former workplace five additional times since 40 Days for Life began its rapid spread to 282 cities across all 50 states and several other countries.
The U.S. Food and Drug Administration today announced that Peng Bandith, owner of the Lao Trading Company of Nashville has signed a consent decree that permanently prohibits Lao Trading Co. from distributing food held under insanitary conditions in interstate commerce.
CEVEC Pharmaceuticals, the German developer of a novel human expression system derived from amniocytes, announced today the signing of an exclusive license option agreement with Pevion Biotech, the Swiss vaccine company. The agreement enables Pevion Biotech to exclusively use CEVEC's transient CAP-T™ cell expression technology to manufacture and commercialize a protein antigen for vaccination against a widespread human infectious disease.
Isis Pharmaceuticals, Inc. today provided an update on its ongoing open-label Phase 2 clinical study of ISIS-SMN Rx in infants with Type I spinal muscular atrophy (SMA).
› Verified 9 days ago
Entity Name | Southern Maine Health Care |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659392819 PECOS PAC ID: 0143208348 Enrollment ID: O20040713001060 |
News Archive
Top Institute Pharma, which carries out pioneering research projects with the support of the Dutch Ministry of Health in order to develop better and safer medicines, is starting a unique research project designed to reduce maternal and child mortality.
The director of the Planned Parenthood abortion center in Bryan/College Station, Texas has resigned her job. Abby Johnson had worked at the clinic for eight years, but departed from the facility following a profound change of heart about abortion. The Planned Parenthood clinic was the location of the first-ever 40 Days for Life campaign in the fall of 2004, and the prayer and fasting initiative has been held outside the doors of Johnson's former workplace five additional times since 40 Days for Life began its rapid spread to 282 cities across all 50 states and several other countries.
The U.S. Food and Drug Administration today announced that Peng Bandith, owner of the Lao Trading Company of Nashville has signed a consent decree that permanently prohibits Lao Trading Co. from distributing food held under insanitary conditions in interstate commerce.
CEVEC Pharmaceuticals, the German developer of a novel human expression system derived from amniocytes, announced today the signing of an exclusive license option agreement with Pevion Biotech, the Swiss vaccine company. The agreement enables Pevion Biotech to exclusively use CEVEC's transient CAP-T™ cell expression technology to manufacture and commercialize a protein antigen for vaccination against a widespread human infectious disease.
Isis Pharmaceuticals, Inc. today provided an update on its ongoing open-label Phase 2 clinical study of ISIS-SMN Rx in infants with Type I spinal muscular atrophy (SMA).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Joseph D Scott, DO 300 Southborough Dr, Suite 201, South Portland, ME 04106-6914 Ph: (207) 661-2018 | Dr Joseph D Scott, DO 2 Springbrook Dr, Biddeford, ME 04005-9443 Ph: (207) 282-1500 |
News Archive
Top Institute Pharma, which carries out pioneering research projects with the support of the Dutch Ministry of Health in order to develop better and safer medicines, is starting a unique research project designed to reduce maternal and child mortality.
The director of the Planned Parenthood abortion center in Bryan/College Station, Texas has resigned her job. Abby Johnson had worked at the clinic for eight years, but departed from the facility following a profound change of heart about abortion. The Planned Parenthood clinic was the location of the first-ever 40 Days for Life campaign in the fall of 2004, and the prayer and fasting initiative has been held outside the doors of Johnson's former workplace five additional times since 40 Days for Life began its rapid spread to 282 cities across all 50 states and several other countries.
The U.S. Food and Drug Administration today announced that Peng Bandith, owner of the Lao Trading Company of Nashville has signed a consent decree that permanently prohibits Lao Trading Co. from distributing food held under insanitary conditions in interstate commerce.
CEVEC Pharmaceuticals, the German developer of a novel human expression system derived from amniocytes, announced today the signing of an exclusive license option agreement with Pevion Biotech, the Swiss vaccine company. The agreement enables Pevion Biotech to exclusively use CEVEC's transient CAP-T™ cell expression technology to manufacture and commercialize a protein antigen for vaccination against a widespread human infectious disease.
Isis Pharmaceuticals, Inc. today provided an update on its ongoing open-label Phase 2 clinical study of ISIS-SMN Rx in infants with Type I spinal muscular atrophy (SMA).
› Verified 9 days ago
Dr. Bruce Elliott Blackman, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 22 W Cole Rd, Biddeford, ME 04005 Phone: 207-283-1118 Fax: 207-286-8792 | |
Kevin Henry Mullarky, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 22 W Cole Rd, C, Biddeford, ME 04005 Phone: 207-284-0176 Fax: 207-286-8792 | |
Leslie S. Dixon, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2 Springbrook Dr, Biddeford, ME 04005 Phone: 207-282-1500 Fax: 207-282-2581 | |
Sara Beth Berner-orcutt, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2 Springbrook Dr, Biddeford, ME 04005 Phone: 207-282-1500 | |
Andrew G. Hinkens, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2 Springbrook Dr, Biddeford, ME 04005 Phone: 207-282-1500 Fax: 207-282-2581 | |
Dr. Donald Rodgers Mcnally Iii, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2 Springbrook Dr, Biddeford, ME 04005 Phone: 207-282-1500 Fax: 207-282-2581 |